Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-10-31
2009-08-25
Mosher, Mary E (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388150, C530S388300, C536S023530, C435S320100, C435S326000, C435S328000, C435S069600, C435S005000, C424S133100, C424S139100, C424S142100, C424S147100
Reexamination Certificate
active
07579446
ABSTRACT:
The invention provides binding molecules that specifically bind to rabies virus and are capable of neutralizing the virus. The invention further provides nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from rabies virus. Preferably, they can be used in the post-exposure prophylaxis of rabies.
REFERENCES:
patent: 2004/0013672 (2004-01-01), Hooper et al.
patent: 7198291 (1991-09-01), None
patent: 0 402 029 (1990-12-01), None
patent: WO 98/15833 (1998-04-01), None
patent: WO 03/016501 (2003-02-01), None
patent: WO 2004/009618 (2004-01-01), None
patent: WO 2005/118644 (2005-12-01), None
Paul, Fundamental Immunology, (textbook), 1993, pp. 292-295. Lippincott-Raven Publishers, Philadelphai, PA.
PCT International Search Report, PCT/EP2005/052410, dated Jan. 1, 2006.
PCT International Preliminary Report on Patentability, PCT/EP2005/052410, dated Aug. 28, 2006.
Prosniak et al., “Development of a Cocktail of Recombinant-Expressed Human Rabies Virus-Neutralizing Monoclonal Antibodies for Postexposure Prophylaxis of Rabies,” Journal of Infectious Diseases, Jul. 1, 2003, pp. 53-56, vol. 188.
Database Genbank NCBI; Jun. 26, 2003, Prosniak, M. et al., “Homo Sapieans anti-rabies S057 immunoglobul in heavy chain mRNA” XP 002356864, retrieved from http://www.ncbi.n1r.nih.gov, Database accession No. AY172957.
Database Genbank NCBI; Jun. 26, 2003, Prosniak, M. et al., “Homo Sapieans anti-rabies S057 immunoglobul in lambda light chain mRNA” XP 002356865, retrieved from http://www.ncbi.n1r.nih.gov, Database accession No. AYI72960.
Champion et al., “The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure,” Journal of Immunological Methods, 2000, pp. 81-90, vol. 235.
Dietzschold et al., “Biological Characterization of Human Monoclonal Antibodies to Rabies Virus,” Journal of Virology, Jun. 1990, pp. 3087-3090, vol. 64, No. 6.
Hanlon et al., “Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis,” Vaccine, 2001, pp. 3834-3842, vol. 19.
Jones et al., “High-level Expression of Recombinant IgG in the Human Cell Line Per.C6,” Biotechnol. Prog., 2003, pp. 163-168, vol. 19.
De Kruif et al., “Selection and Application of Human Single Chain Fv Antibody Fragments from a Semi-synthetic Phage Antibody Display Library with Designed CDR3 Regions,” J. Mol. Biol., 1995, pp. 97-105, vol. 248.
Kramer et al., Abstract, Immunity to infection: The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries, Eur. J. Immunol., 35: 2131-2145 (2005). (Abstract only).
Schumacher et al. “Use of mouse anti-rabies monoclonal antibodies in post-exposure treatment of rabies.”J. Clin. Invest. 84:971-975 (1989).
U.S. Appl. No. 12/227,029, filed Nov. 5, 2008, Inventor: Throsby et al., Title: Human Binding Molecules Having Killing Activity Against Staphylococci and Uses Thereof.
U.S. Appl. No. 12/227,116, filed Nov. 7, 2008, Inventor: Throsby et al., Title: Human Binding Molecules Having Killing Activity Against Enterococci and Uses Thereof.
U.S. Appl. No. 61/199,906, filed Nov. 21, 2008, Inventor: Throsby et al., Title: Antibody Producing Non-Human Mammals.
Bakker Alexander B. H.
de Kruif Cornelius A.
Kramer Robert A.
Marissen Willem E.
Crucell Holland B.V.
Mosher Mary E
TraskBritt
LandOfFree
Binding molecules capable of neutralizing rabies virus and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding molecules capable of neutralizing rabies virus and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding molecules capable of neutralizing rabies virus and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4068693